Psoriasis

Stelara (Ustekinumab) now available for young adults

The biologic treatment Stelara (Ustekinumab) is now available for the treatment of moderate-to-severe plaque psoriasis in adolescents age 12 years and older who have not responded to or are intolerant to other systemic therapies or phototherapies. Psoriasis is an inflammatory skin condition affecting about 2% of the population, which is characterised by red and scaly …

Stelara (Ustekinumab) now available for young adults Read More »

Tonsillectomy may assist patients with recalcitrant psoriasis

Tonsillectomy may be an option that can result in improvement in psoriasis, for patients with recalcitrant psoriasis associated with episodes of tonsillitis, according to a review published in the February issue of the Journal of the American Academy of Dermatology. Researchers reviewed 20 studies involving 545 psoriasis patients who were evaluated for or underwent tonsillectomy. …

Tonsillectomy may assist patients with recalcitrant psoriasis Read More »

Scroll to Top